Pharma giant Eli Lilly and Company is teaming up with Germany-based BioNTech to discover novel cancer immunotherapies. The companies have entered into a research collaboration to discover new cancer drugs, which use the body’s own immune system to attack cancer cells and create possible new treatment options for patients with …